GlobalData on MSN19h
BeiGene’s PD-1 drug approved in EU for first-line oesophageal cancer treatment
The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...
Dr Reddy’s launch anti-cancer drug for aggressive head and neck cancer
The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...
The “Holiday Pause” For GLP-1s Is Quickly Approaching — but Is It Safe?
Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...
US FDA declines to approve Applied Therapeutics' genetic disease drug
Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...
HIV Breakthrough as New Injection 89% More Effective Than PrEP
"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...
FDA probes blood cancer risk from bluebird's gene therapy, weighs regulatory action
The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...
JD Supra17h
FDA Provides Perspective on Goals and Challenges for Regulation of Artificial Intelligence in Medical Devices, Drug Design, and Clinical Research
A recent article authored by Haider J. Warraich, MD; Troy Tazbaz; and Robert M. Califf, MD in the Journal of the American ...
healthday1h
Twice-Yearly Injection 96% Effective in Preventing HIV Infection
People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themsel ...
Doctors and epilepsy patients urge Sask. government to seek deal on new anti-seizure drug
The call for public funding for Xcopri, a new epilepsy drug recently approved by Health Canada, brought physicians and ...
Dr Reddy's launches Toripalimab to treat nasopharyngeal cancer in India
In 2023, Dr Reddy's signed a licensing and commercialisation agreement with Shanghai Junshi Biosciences for Toripalimab ...
Wegovy approved in Canada to combat risk of non fatal-heart attack
Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial ...
Scientists Develop Whole New Form of Effective Asthma Treatment
Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, ...